This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Recurrent Non-Small Cell Lung Carcinoma or Stage IV Non-Small Cell Lung Cancer
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This phase II trial studies how well nivolumab works in treating patients with stage IV lung cancer or that has come back after initial treatment who has high mutation loads. Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells.

Provided treatments

  • Biological: Nivolumab
  • Other: Laboratory Biomarker Analysis

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023904. The sponsor of the trial is Vanderbilt-Ingram Cancer Center and it is looking for 0 volunteers for the current phase.
Official trial title:
Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads